By

By

By

Taren Grom, Editor

On The Cover

Competitive Intelligence: The Eyes and Ears of the Industry
The need to gain a competitive advantage has never been greater, and competitive-intelligence (CI) teams are evolving to meet the industry’s current and future challenges. Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the factors that are creating a tougher environment for industry players and prompting the [...]

By

Elisabeth Pena Villarroel

Features

Alzheimer’s Disease: Untangling the Brain’s Mystery
By Cynthia Borda As the population ages, the prevalence of Alzheimer’s disease (AD) is expected to increase. But there is no real way to diagnose the disease and drugs currently on the market only treat the symptoms of Alzheimer’s. At the same time, analysts say there is tremendous opportunity for pharmaceutical companies in this market, [...]

By

Cynthia Borda

The New Detail: Creating Value
Preserving access for representatives with physicians and creating win-win relationships are two major challenges facing the industry, but opportunities exist for creative people committed to healthcare and the value of medicine. The new reality of medical practice is that time is a very limited commodity. Today’s practice managers track physician productivity. Because patient visits equal [...]

By

HBA Unleashes the Power of Being
Becoming an Agent of Change Was the Focus of the 2005 Leadership Conference by Marie Tartaglio, M.Ed., Director, Training & Learning Strategy, Scientific Advantage LLC, and Donna Ramer, President, StrategCations Inc., Member, HBA Board of Directors “Successful leaders are adept at mastering change, and most companies want their employees to be agents of change,” said [...]

By

Marie Tartaglio, M.Ed, and Donna Ramer

Sense and Sensibility — Pamela Williamson Joyce
With a wide and deep understanding of the inner sanctum of numerous departments in the life sciences, Pamela Williamson Joyce has been able to bring both inventiveness and clear-headed thinking to Serono’s regulatory practice, helping the company to bring many new products to market. The path to drug approval is a long and complex one, [...]